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aneurysms
Shirling Tsai, Mark F. Conrad, Virendra I. Patel, Christopher J. Kwolek, Glenn
M. LaMuraglia, David C. Brewster, Richard P. Cambria
Objective: As branched/fenestrated endografts expand endovascular
options for juxtarenal abdominal aortic aneurysms (JAAAs), long-term
durability will be compared to that of open JAAA repair, which has not
been documented in large contemporary series. The goal of this study
was to assess the late clinical and anatomic outcomes after open JAAA
repair.
Methods: From July 2001 to December 2007, 199 patients underwent open
elective JAAA repair, as deﬁned by a need for suprarenal clamping. End
points included perioperative and late survival, long-term follow-up of
renal function, and freedom from graft-related complications. Factors
predictive of survival were determined by multivariate analysis. RESULTS:
The mean patient age was 74 years, 71% were men, and 20% had baseline
renal insufﬁciency (Cr >1.5). Thirty-seven renal artery bypasses, for
anatomic necessity or ostial stenosis, were performed in 36 patients.
Overall 30-day mortality was 2.5%. Four patients (2.0%) required early
dialysis; one patient recovered by discharge. Two additional patients
progressed to dialysis over long-term follow-up. There was one graft
infection involving one limb of a bifurcated graft. Surveillance imaging was
obtained in 101 patients (72% of survivors) at a mean follow-up of 41 ± 28
months. Renal artery occlusion occurred in four patients (3% of imaged
renal arteries; one native/three grafts). Two patients (2.0%) had aneu-
rysmal degeneration of the aorta either proximal or distal to the repaired
segment, but there were no anastomotic pseudoaneurysms. Remote
aneurysmswere found in 29 patients (29% of imaged patients),14 of whom
had descending thoracic aneurysm or TAAA. Four patients underwent
subsequent thoracic endovascular aneurysm repair (TEVAR). Actuarial
survival was 74 ± 3.3% at 5 years. Negative predictors of survival included
increasing age at the time of operation (relative risk [RR], 1.05; P ¼ .01),
steroid use (RR, 2.20; P ¼ .001), and elevated preoperative creatinine (RR,
1.73; P ¼ .02).
Conclusions: Open JAAA repair yields excellent long-term anatomic
durability and preserves renal function. Perioperative renal insufﬁ-
ciency occurs in 8.5% of patients, but few of them progress to dialysis.
Graft-related complications are rare (2% at 40 months); however, axial
imaging revealed descending thoracic aneurysms in 14% of imaged
patients, making continued surveillance for remote aneurysms
prudent. These data provide a benchmark against which fenestrated/
branched endovascular aneurysm repair (EVAR) outcomes can be
compared.q Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(12)00382-6Thirty-day outcome and quality of life after endovascular abdominal
aortic aneurysm repair in octogenarians based on the Endurant
Stent Graft Natural Selection Global Postmarket Registry (ENGAGE)
Robert A. Pol, Clark J. Zeebregts, Steven M.M. van Sterkenburg, Michel
M.P.J. Reijnen
Objectives: To determine 30-day outcome and quality of life after elective
endovascular abdominal aortic aneurysm repair in octogenarians.
Methods: From March 2009 to May 2011, 1200 patients with abdominal
aortic aneurysms were treated with endovascular aneurysm repair (EVAR)
using the Endurant stent graft were included in the Endurant Stent Graft
Natural Selection Global Postmarket Registry (ENGAGE) registry. Among
these, 926 (77%) were aged<80 years, and 274 (23%) were aged80 years.
Quality of life was assessed using composite EuroQoL 5-Dimensions
Questionnaire index scores. RESULTS: Gender was unequally distributed,
with more female patients among the octogenarians (P ¼ .043). Octoge-
narians had a signiﬁcantly higher American Society of Anesthesiologists
classiﬁcation (P < .001) and differed signiﬁcantly in baseline risk factors.
The younger cohort was more likely to smoke (P < .001) and be alcoholics
(P ¼ .005). Octogenarians had larger aortic aneurysm (P ¼ .010) and
left iliac artery diameters (P ¼ .017) and greater infrarenal neck angulation
(P ¼ .01). The technical success rate was >99% for both cohorts. Octoge-
narians were more often operated on under general anesthesia (P ¼ .028),
had a longer procedure duration (P ¼ .001), and an increased length of
hospitalization; both total (P < .001) and postprocedure (P < .001). All-
cause mortality and major adverse event rates were similar in the two
groups (P ¼ .835 and P ¼ .186, respectively). There was no difference in the
number of secondary endovascular procedures or aneurysm rupture at 30
days. At discharge, both groups had reduced health status dimensions,
except anxiety/depression, when compared with baseline. At 30 days, the
octogenarian group had a lower composite EuroQoL 5-Dimensions Ques-
tionnaire index compared with the younger group indicating a slower
recovery (0.83 ± 0.20 vs 0.87 ± 0.16; P ¼ .003).
Conclusions: Octogenarians can be safely treated using the Endurant stent
graft with a high technical rate of success, low perioperative mortality, and
no reduction in quality of life. Octogenarians did, however, appear to
recover more slowly than younger patients with respect to certain quality
of life components. Long-term data are needed to conﬁrm these results.
The inﬂuence of neck thrombus on clinical outcome and aneurysm
morphology after endovascular aneurysm repair
Frederico Bastos Gonçalves, Hence J.M. Verhagen, Khamin Chinsakchai,
Jasper W. van Keulen, Michiel T. Voûte, Herman J. Zandvoort, Frans L. Moll,
Joost A. van Herwaarden
Objective: This study investigated the inﬂuence of signiﬁcant aneurysm
neck thrombus in clinical and morphologic outcomes after endovascular
aneurysm repair (EVAR).
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database from two university institutions in The Netherlands from 2004 to
2008. Patients with signiﬁcant thrombus in the neck (>2 mm in thickness
in at least >25% of circumference) were identiﬁed as the thrombus group
and were compared with the remaining patients without neck thrombus
(no-thrombus group), treated within the same period. The primary end
point was clinical success. Secondary end points included technical success
and rates of decline in renal function. Detailed morphologic analysis of the
aortic neck was serially performed for the thrombus group patients to
assess changes in thrombus volume.
Results: The study included 389 patients: 43 (39 men; mean age of 72.3
years) met the criteria for the thrombus group; of these, 31 (72%) had
signiﬁcant thrombus in >50% of the aortic neck circumference, and 8 (19%)
had circumferential thrombus >2-mm thick. Median follow-up was 3.34
years (interquartile range, 2.67-4.72). The estimated 5-year clinical success
rate was 74% for the thrombus group and 62% for the no-thrombus group
(P ¼ .23). Endograft migration was more frequent in the thrombus group
(P ¼ .02). Multivariable Cox regression analysis showed a signiﬁcant
association between migration and use of a device without active ﬁxation
(hazard ratio, 4.9; 95% conﬁdence interval, 1.31-18.23, P ¼ .018) but not
with the presence of neck thrombus (P ¼ .063). No differences were found
in the rates of decline in estimated glomerular ﬁltration rate (eGFR) at 30
days and during follow-up between the thrombus and no-thrombus
groups. The thrombus volume in the ﬁrst 10 mm of aortic neck was
progressively reduced over time until it was not measurable in most
patients, resulting in complete circular attachment of the endograft to the
vessel wall.
Conclusions: Our ﬁndings suggest that the presence of aneurysm neck
thrombus has no signiﬁcant inﬂuence on short-term and midterm EVAR
results.
Prediction of asymptomatic abdominal aortic aneurysm expansion
by means of rate of variation of C-reactive protein plasma levels
Joaquin De Haro, Francisco Acin, Silvia Bleda, Cesar Varela, Francisco J.
Medina, Leticia Esparza
Objective: C-reactive protein (CRP) is an independent risk factor for arte-
riosclerosis, but its role in abdominal aortic aneurysm (AAA) expansion
remains not completely veriﬁed. There are no data about the prognostic
signiﬁcance of rates of variation of the CRP levels in asymptomatic AAAs.
This study investigated the association between plasma CRP levels and
AAA diameter and assessed the relationship between the gradient of CRP
levels and rates of expansion in asymptomatic AAAs.
Methods: Plasma levelsofhigh-sensitiveCRP(hs-CRP)weremeasuredusing
a high-sensitivity technique and AAA size was determined by computed
tomography in 435 patients with asymptomatic AAAs followed up in our
outpatient department.
Results: The median hs-CRP level was 4.23 mg/L. The aorta diameter
increased in the four groups of patients determined according to hs-CRP
quartiles (35 û ô 2, 40 û ô 3, 49 û ô 4, and 58 û ô 5 mm; P ¼ .01). The
median rate of CRP level variation per year was 1.4 mg/L. Patients with an
elevation >1.4 mg/L had an expansion rate of 4.8 mm vs 3.9 mm in those
<1.4 mg/L (P < .01). The multivariate age-adjusted logistic model
conﬁrmed initial diameter and variation of CRP level were the only factors
associated with expansion, with odds ratios (95% conﬁdence intervals) of
6.3 (3.1-7.5) and 3.4 (2.1-5.6).
Conclusions: These results conﬁrm a statistical association between AAA
diameter and hs-CRP plasma levels. This cohort study corroborates this
potential causal association and contributes information about the value of
the hs-CRP plasma level gradient as a marker of disease progression and
rate of expansion.
Comparing the embolic potential of open and closed cell stents
during carotid angioplasty and stenting
Rami O. Tadros, Constantinos T. Spyris, Ageliki G. Vouyouka, Christine
Chung, Prakash Krishnan, Margaret W. Arnold, Michael L. Marin, Peter L.
Faries̆ ̆ ̆ ̆Objective: We sought to determine the effects of open (O) and closed (C)
cell stents on the size and number of embolic particles generated during
carotid artery stenting (CAS) and assess the impact on outcome.
Methods: Embolic debris from carotid ﬁlters after CAS was analyzed using
photomicroscopy and imaging software. Patient comorbidities, preopera-
tive cerebrovascular symptoms, stent type, and outcomes (perioperative
major adverse events [MAEs]) were examined.
Results: Carotid ﬁlters from 173 consecutive CAS procedures (O, 125 and C,
48) were reviewed. The mean age was 70.9 9.2 years; 58% were men.
Mean stenosis was 88.2%8.1%; 36.6% had neurological symptoms pre-
procedurally. There was no difference in preoperative symptoms between
the two groups (O, 38.7% vs C, 31.3%; P ¼ not signiﬁcant [NS]). However,
closed cell stent use was associated with higher degree of stenosis (O,
87.2% 8.0% vs C, 90.6% 7.8%; P¼.01), an older age (O, 70.0 8.6 years vs
C, 73.4  10.2 years; P ¼ .03), and peripheral arterial disease (PAD; 21.1% vs
43.5%; P¼ .01). A largermean particle size was observed in patients treated
with open cell stents compared to closed cell stents (O, 416.5 335.7 mmvs
C, 301.1251.3 mm; P¼ .03). Therewas no signiﬁcant difference in the total
number of particles (O,13.8 21.5 vs C,17.6 19.9; P¼NS), periprocedural
stroke (P ¼ NS), and MAEs between the two groups (P ¼ NS).
Conclusions: Open cell stents are associated with a larger mean particle
size compared to closed cell stents. No impact on procedural outcomes
based on stent type was observed.
Failed superﬁcial femoral artery intervention for advanced
infrainguinal occlusive disease has a signiﬁcant negative impact on
limb salvage
Omar Al-Nouri, Monika Krezalek, Richard Hershberger, Pegge Halandras,
Andrew Gassman, Bernadette Aulivola, Ross Milner
Objective: Endovascular treatment of superﬁcial femoral artery (SFA)
lesions is a well-established practice. The repercussions of failed SFA
interventions are unclear. Our goal was to review the efﬁcacy of SFA
stenting and deﬁne negative effects of its failure.
Methods: A retrospective chart review was conducted from January 2007
to January 2010 that identiﬁed 42 limbs in 39 patients that underwent SFA
stenting. Follow-up ankle-brachial index and a duplex ultrasound scanwas
performed at routine intervals.
Results:Mean patient agewas 68 years (range, 43-88 years), there were 22
men (56%) and 17 women (44%). Intervention indication was claudication
in 15 patients (36%), rest pain in seven patients (17%), and tissue loss in 19
patients (45%). There were 15 patients (36%) with TransAtlantic Inter-
Society Consensus (TASC) A, nine patients (21%) with TASC B, ﬁve patients
(12%) with TASC C, and 13 patients (31%) with TASC D lesions. The majority
of lesions intervened on were the ﬁrst attempt at revascularization. Three
stents (7.7%) occluded within 30 days. One-year primary, primary-assisted,
and secondary patency rates were 24%, 44%, and 51%, respectively. Limb
salvage was 93% during follow-up. Seventeen interventions failed (40%) at
1 year. Of these, seven patients (41%) developed claudication, seven
patients (41%) developed ischemic rest pain, and three patients (18%) were
asymptomatic. During follow-up, three patients (7.7%) required bypass and
three patients (7.7%) major amputation, one after failed bypass. All limbs
requiring bypass or amputation had TASC C/D lesions. Thirty-day and 1-
year mortality was 2.6% and 10.3%, respectively.
Conclusion: Interventions performed for TASC C/D lesions are more likely
to fail and more likely to lead to bypass or amputation. Interventions
performed for TASC C/D lesions that fail have a negative impact on limb
salvage. This should be considered when performing stenting of advanced
SFA lesions.
A prospective randomized study comparing ﬁbrin sealant to manual
compression for the treatment of anastomotic suture-hole bleeding
in expanded polytetraﬂuoroethylene grafts
Sibu P. Saha, Satish Muluk, Worthington Schenk, James W. Dennis, Bettina
Ploder, Ani Grigorian, Isabella Presch, Andreas Goppelt
Objective: The ideal hemostatic agent for treatment of suture-line bleeding
at vascular anastomoses has not yet been established. This study evaluated
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synthetic aprotinin (FS; marketed in the United States under the name
TISSEEL) is beneﬁcial for treatment of challenging suture-line bleeding at
vascular anastomoses of expanded polytetraﬂuoroethylene (ePTFE) grafts,
including those further complicated by concomitant antiplatelet
therapies.
Methods: Over a 1-year period ending in 2010, ePTFE graft prostheses,
including arterio-arterial bypasses and arteriovenous shunts were placed
in 140 patients who experienced suture-line bleeding that required
treatment after completion of anastomotic suturing. Across 24 US study
sites, 70 patients were randomized and treated with FS and 70 with
manual compression (control). The primary endpoint was the proportion
of patients who achieved hemostasis at the study suture line at 4 minutes
after start of application of FS or positioning of surgical gauze pads onto the
study suture line.
Results: There was a statistically signiﬁcant difference in the comparison
of hemostasis rates at the study suture line at 4 minutes between FS
(62.9%) and control (31.4%) patients (P < .0001), which was the primary
endpoint. Similarly, hemostasis rates in the subgroup of patients on
antiplatelet therapies were 64.7% (FS group) and 28.2% (control group).
When analyzed by bleeding severity, the hemostatic advantage of FS over
control at 4 minutes was similar (27.8% absolute improvement for
moderate bleeding vs 32.8% for severe bleeding). Logistic regression
analysis (accounting for gender, age, intervention type, bleeding severity,
blood pressure, heparin coating of ePTFE graft, and antiplatelet therapies)
found a statistically signiﬁcant treatment effect in the odds ratio (OR) of
meeting the primary endpoint between treatment groups (OR, 6.73; P <
.0001), as well as statistically signiﬁcant effects for intervention type (OR,
0.25; P ¼ .0055) and bleeding severity (OR, 2.59; P ¼ .0209). The safety
proﬁle of FS was excellent as indicated by the lack of any related serious
adverse events.
Conclusions: The ﬁndings from this phase 3 study conﬁrmed that FS is
safe and its efﬁcacy is superior to manual compression for hemostasis
in patients with peripheral vascular ePTFE grafts. The data also suggest
that FS promotes hemostasis independently of the patient’s own
coagulation system, as shown in a representative population ofpatients with vascular disease under single- or dual-antiplatelet
therapies.
Long-term result of endovascular treatment for patients with
nutcracker syndrome
Xiaobai Wang, Yan Zhang, Chengzhi Li, Hong Zhang
Objective: To retrospectively assess the therapeutic value of endovascular
stenting for treatment of the nutcracker syndrome (NCS) in long-term
follow-up and to explore the selection of the size of stents in Chinese
patients with NCS.
Methods: From January2004 toAugust 2010,30patients (twowomenand28
men)between13and32yearsold (mean,18.2)whowerediagnosedwithNCS
were admitted for endovascular treatment. Each patient received one self-
expanding metallic stent (14-mm diameter, 60 mm long) in the compressed
portion of the left renal vein during the operation, and three patients with
severe left-sided varicoceles received left gonadal vein embolization. The
postoperative follow-up was 12 to 80 months (median, 36.0 months).
Results: The diameters at the ostium of left renal vein measured by the
ultrasonic examination before treatment were 11.8 ± 1.8 mm. Technical
success of operation was achieved in all patients. No perioperative
complications occurred. Two cases of stent migration were found at 12
months: both stents prolapsed into the inferior vena cava, with uneventful
follow-up (49 and 56months, respectively). At 1-month follow-up, patients
improved, including two patients who had persistent but less microscopic
hematuria than before treatment. The clinical symptoms related to NCS
almost disappeared at 3 months after the treatment. All stents were patent
at the duplex scan examination, without restenosis, and no secondary
recurrence of the symptoms occurred at the end of the follow-up.
Conclusions: Endovascular treatment is a safe, effective, and very mini-
mally invasive technique that provides good long-term patency rates for
patients with NCS, and under the premise morphologic measurements, 14-
mm-diameter, 60-mm-long self-expanding stents should be ﬁrst consid-
ered for Chinese patients with NCS.
